Bringspring Science and Technology issued a clarification announcement. The company recently noticed market rumors and exaggerated interpretations of normal personnel changes, combined with previous market rumors, once again fueled market hotspots such as asset injection and backdoor listing "super fusion", causing abnormal fluctuations in stock prices. In order to avoid misleading investors with relevant information, we now clarify: 1. The adjustment of company's board of directors is a normal management work for strengthening the company's governance. At present, the company's operation is normal and the core team is stable. 2. After verifying with the company's controlling shareholder and board of directors, the company does not have any unannounced asset injections, acquisitions or reorganizations that should have been disclosed.
荣科科技澄清：公司董事会成员调整，为加强公司治理需要，系股东正常管理工作
Bringspring Science and Technology clarified: adjustment of company's board of directors is a normal management work for strengthening the company's governance.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.